Baxter International (0QK8) Share Forecast & Price Target

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0QK8 Analyst Ratings

Hold

1 Buy

9 Hold

0 Sell

Based on 10 analysts giving stock ratings to

Baxter

International

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0QK8 Stock 12 Month Forecast

Average Price Target

$25.90

▲(11.78% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Baxter International in the last 3 months. The average price target is $25.90 with a high forecast of $29.00 and a low forecast of $21.00. The average price target represents a 11.78% change from the last price of $23.17.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"$16","23":"$23","30":"$30","19.5":"$19.5","26.5":"$26.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":29,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$29.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":25.9,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$25.90</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$21.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[16,19.5,23,26.5,30],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.92,26.15692307692308,26.393846153846155,26.630769230769232,26.86769230769231,27.104615384615386,27.341538461538462,27.57846153846154,27.815384615384616,28.052307692307693,28.28923076923077,28.526153846153846,28.763076923076923,{"y":29,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.92,25.91846153846154,25.916923076923077,25.915384615384617,25.913846153846155,25.912307692307692,25.91076923076923,25.90923076923077,25.907692307692308,25.906153846153845,25.904615384615383,25.903076923076924,25.90153846153846,{"y":25.9,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.92,25.54153846153846,25.163076923076925,24.784615384615385,24.40615384615385,24.02769230769231,23.64923076923077,23.270769230769233,22.892307692307693,22.513846153846153,22.135384615384616,21.756923076923076,21.37846153846154,{"y":21,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":24.523,"date":1756674000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.901,"date":1759266000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.511,"date":1761948000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.043,"date":1764540000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.252,"date":1767218400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.86,"date":1769896800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.552,"date":1772316000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.104,"date":1774990800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.344,"date":1777582800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.513,"date":1780261200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.661,"date":1782853200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.27,"date":1785531600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":25.92,"date":1788210000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$29.00

Average Price Target$25.90

Lowest Price Target$21.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Joanne Wuensch

Citi

$28

Hold

20.85%

Upside

Reiterated

08/13/26

Baxter International (BAX) Gets a Hold from Citi

Travis Steed

Bank of America Securities

$20→$28

Hold

20.85%

Upside

Reiterated

08/11/26

Bank of America Securities Sticks to Its Hold Rating for Baxter International (BAX)

Robbie Marcus

J.P. Morgan

$26

Hold

12.21%

Upside

Reiterated

08/06/26

J.P. Morgan Sticks to Their Hold Rating for Baxter International (BAX)

Unknown Analyst

Wells Fargo

Not Ranked

Wells Fargo

$19→$23

Hold

-0.73%

Downside

Assigned

07/31/26

Baxter International (BAX) Gets a Hold from Wells Fargo

Pito Chickering

Deutsche Bank

$20→$27

Hold

16.53%

Upside

Reiterated

07/31/26

Baxter price target raised to $27 from $20 at Deutsche BankBaxter price target raised to $27 from $20 at Deutsche Bank

Josh Jennings

TD Cowen

$24→$29

Hold

25.16%

Upside

Reiterated

07/31/26

Analysts Conflicted on These Healthcare Names: Karyopharm Therapeutics (NASDAQ: KPTI), Baxter International (NYSE: BAX) and Alnylam Pharma (NASDAQ: ALNY)

Rick Wise

Stifel Nicolaus

$24→$28

Hold

20.85%

Upside

Reiterated

07/31/26

Baxter price target raised to $24 from $19 at StifelBaxter price target raised to $24 from $19 at Stifel

Patrick Wood

UBS

$19→$25

Hold

7.90%

Upside

Assigned

07/28/26

Analysts Conflicted on These Healthcare Names: Baxter International (NYSE: BAX), Incyte (NASDAQ: INCY) and Argenx Se (NASDAQ: ARGX)

David Roman

Goldman Sachs

$19→$21

Hold

-9.37%

Downside

Assigned

07/15/26

Baxter price target raised to $21 from $19 at Goldman SachsBaxter price target raised to $21 from $19 at Goldman Sachs

Vijay Kumar

Evercore ISI

$22→$24

Buy

3.58%

Upside

Reiterated

07/06/26

Baxter price target raised to $24 from $22 at Evercore ISIBaxter price target raised to $24 from $22 at Evercore ISI

Steven Silver

Argus Research

―

Hold

―

Reiterated

05/08/26

Analysts Offer Insights on Healthcare Companies: Baxter International (NYSE: BAX) and Capricor Therapeutics (NASDAQ: CAPR)

Matt Miksic

Barclays

$25→$27

Buy

16.53%

Upside

Reiterated

05/04/26

Analysts Are Bullish on Top Healthcare Stocks: Alkermes (ALKS), Baxter International (BAX)

Matthew Taylor

Jefferies

$21→$19

Hold

-18.00%

Downside

Reiterated

02/12/26

Baxter price target lowered to $19 from $21 at JefferiesBaxter price target lowered to $19 from $21 at Jefferies

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Joanne Wuensch

Citi

$28

Hold

20.85%

Upside

Reiterated

08/13/26

Baxter International (BAX) Gets a Hold from Citi

Travis Steed

Bank of America Securities

$20→$28

Hold

20.85%

Upside

Reiterated

08/11/26

Bank of America Securities Sticks to Its Hold Rating for Baxter International (BAX)

Robbie Marcus

J.P. Morgan

$26

Hold

12.21%

Upside

Reiterated

08/06/26

J.P. Morgan Sticks to Their Hold Rating for Baxter International (BAX)

Unknown Analyst

Wells Fargo

Not Ranked

Wells Fargo

$19→$23

Hold

-0.73%

Downside

Assigned

07/31/26

Baxter International (BAX) Gets a Hold from Wells Fargo

Pito Chickering

Deutsche Bank

$20→$27

Hold

16.53%

Upside

Reiterated

07/31/26

Baxter price target raised to $27 from $20 at Deutsche BankBaxter price target raised to $27 from $20 at Deutsche Bank

Josh Jennings

TD Cowen

$24→$29

Hold

25.16%

Upside

Reiterated

07/31/26

Analysts Conflicted on These Healthcare Names: Karyopharm Therapeutics (NASDAQ: KPTI), Baxter International (NYSE: BAX) and Alnylam Pharma (NASDAQ: ALNY)

Rick Wise

Stifel Nicolaus

$24→$28

Hold

20.85%

Upside

Reiterated

07/31/26

Baxter price target raised to $24 from $19 at StifelBaxter price target raised to $24 from $19 at Stifel

Patrick Wood

UBS

$19→$25

Hold

7.90%

Upside

Assigned

07/28/26

Analysts Conflicted on These Healthcare Names: Baxter International (NYSE: BAX), Incyte (NASDAQ: INCY) and Argenx Se (NASDAQ: ARGX)

David Roman

Goldman Sachs

$19→$21

Hold

-9.37%

Downside

Assigned

07/15/26

Baxter price target raised to $21 from $19 at Goldman SachsBaxter price target raised to $21 from $19 at Goldman Sachs

Vijay Kumar

Evercore ISI

$22→$24

Buy

3.58%

Upside

Reiterated

07/06/26

Baxter price target raised to $24 from $22 at Evercore ISIBaxter price target raised to $24 from $22 at Evercore ISI

Steven Silver

Argus Research

―

Hold

―

Reiterated

05/08/26

Analysts Offer Insights on Healthcare Companies: Baxter International (NYSE: BAX) and Capricor Therapeutics (NASDAQ: CAPR)

Matt Miksic

Barclays

$25→$27

Buy

16.53%

Upside

Reiterated

05/04/26

Analysts Are Bullish on Top Healthcare Stocks: Alkermes (ALKS), Baxter International (BAX)

Matthew Taylor

Jefferies

$21→$19

Hold

-18.00%

Downside

Reiterated

02/12/26

Baxter price target lowered to $19 from $21 at JefferiesBaxter price target lowered to $19 from $21 at Jefferies

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

SNDXSyndax Pharmaceuticals

PTGXProtagonist Therapeutics

ONCBeOne Medicines

HITIHigh Tide

IRTCIrhythm Technologies

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Baxter International

3 Months

Matt MiksicBarclays

Success Rate

9/29 ratings generated profit

Average Return

-1.83%

Copying Matt Miksic's trades and holding each position for 3 Months would result in 31.03% of your transactions generating a profit, with an average return of -1.83% per trade.

1 Year

Matt MiksicBarclays

Success Rate

15/29 ratings generated profit

Average Return

+1.84%

Copying Matt Miksic's trades and holding each position for 1 Year would result in 51.72% of your transactions generating a profit, with an average return of +1.84% per trade.

2 Years

Matt MiksicBarclays

Success Rate

12/29 ratings generated profit

Average Return

-4.97%

Copying Matt Miksic's trades and holding each position for 2 Years would result in 41.38% of your transactions generating a profit, with an average return of -4.97% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0QK8 Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0QK8 has received 1 Buy Ratings, 12 Hold Ratings, and 1 Sell Ratings. 0QK8 average Analyst price target in the past 3 months is 25.90.

Each month's total comprises the sum of three months' worth of ratings.

0QK8 Financial Forecast

0QK8 Earnings Forecast

Next quarter’s earnings estimate for 0QK8 is $0.52 with a range of $0.50 to $0.54. The previous quarter’s EPS was $0.56. 0QK8 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0QK8 has Performed in-line its overall industry.

0QK8 Sales Forecast

Next quarter’s sales forecast for 0QK8 is $2.91B with a range of $2.88B to $2.92B. The previous quarter’s sales results were $2.96B. 0QK8 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0QK8 has Performed in-line its overall industry.

0QK8 Stock Forecast FAQ

What is GB:0QK8’s average 12-month price target, according to analysts?

Based on analyst ratings, Baxter International’s 12-month average price target is 25.90.

What is GB:0QK8’s upside potential, based on the analysts’ average price target?

Baxter International has 11.78% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Baxter International a Buy, Sell or Hold?

Baxter International has a consensus rating of Hold, which is based on 1 buy ratings, 9 hold ratings and 0 sell ratings.

What is Baxter International’s share price target?

The average share price target for Baxter International is 25.90. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $29.00 ,and the lowest forecast is $21.00. The average share price target represents 11.78% Increase from the current price of $23.17.

What do analysts say about Baxter International?

Baxter International’s analyst rating consensus is a Hold. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of Baxter International?

To buy shares of GB:0QK8, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Baxter International (0QK8) Share Forecast & Price Target

0QK8 Analyst Ratings

0QK8 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Baxter International

0QK8 Analyst Recommendation Trends

0QK8 Financial Forecast

0QK8 Earnings Forecast

0QK8 Sales Forecast

0QK8 Stock Forecast FAQ

Detailed List of Analyst Forecasts